Detalhe da pesquisa
1.
HSP110 sustains chronic NF-κB signaling in activated B-cell diffuse large B-cell lymphoma through MyD88 stabilization.
Blood
; 132(5): 510-520, 2018 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29871863
2.
The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size.
EMBO Rep
; 19(12)2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30337494
3.
Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities.
Cancer Immunol Immunother
; 67(11): 1797-1807, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203262
4.
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
Blood
; 127(22): 2732-41, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27048211
5.
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
J Allergy Clin Immunol
; 140(4): 1054-1067.e10, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28216434
6.
A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance.
Hepatology
; 62(5): 1375-87, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26250868
7.
Activation of lymphoma-associated MyD88 mutations via allostery-induced TIR-domain oligomerization.
Blood
; 124(26): 3896-904, 2014 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25359991
8.
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.
Vaccines (Basel)
; 12(4)2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38675770
9.
Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189].
Vaccine X
; 14: 100307, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131960
10.
A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant.
Vaccines (Basel)
; 10(4)2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455257
11.
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study.
Vaccine X
; 11: 100189, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791320
12.
Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-κB Signaling.
Front Immunol
; 12: 616451, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34163463
13.
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Wien Klin Wochenschr
; 133(17-18): 931-941, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378087
14.
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.
J Exp Med
; 218(11)2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34554188
15.
Putative link between Polo-like kinases (PLKs) and Toll-like receptor (TLR) signaling in transformed and primary human immune cells.
Sci Rep
; 9(1): 13168, 2019 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511529
16.
Examining Myddosome Formation by Luminescence-Based Mammalian Interactome Mapping (LUMIER).
Methods Mol Biol
; 1714: 119-130, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29177859
17.
HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.
Oncoimmunology
; 6(3): e1219825, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405493